Apoptosis in isolated adult cardiomyocytes exposed to adriamycin

D Kumar1, L Kirshenbaum, T Li

  • 1St. Boniface General Hospital Research Centre, Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.

Insights

Adriamycin (doxorubicin) can cause heart failure through cell death. The antioxidant trolox significantly reduced this adriamycin-induced apoptosis and necrosis in rat heart cells.

Area of Science:

  • Cardiology
  • Toxicology
  • Cell Biology

Background:

  • Adriamycin (doxorubicin) is a crucial chemotherapy drug.
  • Its clinical use is limited by cardiotoxicity, specifically cardiomyopathy and heart failure.
  • Oxidative stress is implicated in adriamycin-induced cardiotoxicity.

Purpose of the Study:

  • To investigate adriamycin-induced apoptosis in isolated adult rat cardiomyocytes.
  • To determine if trolox, a water-soluble antioxidant, can inhibit adriamycin-induced cell death.

Main Methods:

  • Isolated adult rat cardiomyocytes were exposed to adriamycin (20 microM for 1 h).
  • Cell viability was assessed via cell shape changes, Hoechst 33258 staining, and TUNEL assay.
  • DNA fragmentation was analyzed using agarose gel electrophoresis (DNA laddering).
  • The effects of trolox treatment were evaluated.

Main Results:

  • Adriamycin exposure led to a decrease in rod-shaped cells and an increase in rounded cells.
  • Increased myocyte apoptosis and nucleosomal fragmentation were observed.
  • DNA laddering and a smear indicating indiscriminate DNA fragmentation (necrosis) were evident.
  • Trolox significantly reduced both apoptosis and necrosis.

Conclusions:

  • Adriamycin induces cardiomyocyte death through both apoptosis and necrosis.
  • Oxidative stress likely mediates these cell death pathways.
  • Trolox demonstrates a protective effect against adriamycin-induced cardiotoxicity.